<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To investigate the association between serum <z:chebi fb="3" ids="27226">uric acid</z:chebi> level and risk of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: The population for analysis consisted of 4,536 subjects free from <z:mp ids='MP_0002055'>diabetes</z:mp> at baseline </plain></SENT>
<SENT sid="2" pm="."><plain>During a mean of 10.1 years of follow-up, 462 subjects developed <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: The age- and sex-adjusted hazard ratios (HRs) (95% CIs) for <z:mp ids='MP_0002055'>diabetes</z:mp> were 1.30 (0.96-1.76) for the second, 1.63 (1.21-2.19) for the third, and 2.83 (2.13-3.76) for the fourth quartile of serum <z:chebi fb="3" ids="27226">uric acid</z:chebi>, in comparison with the first quartile </plain></SENT>
<SENT sid="4" pm="."><plain>After adjustment for BMI, waist circumference, systolic and diastolic blood pressure, and <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi>, the HRs decreased to 1.08 (0.78-1.49), 1.12 (0.81-1.53), and 1.68 (1.22-2.30), respectively </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSIONS: The results of this population-based study suggest that serum <z:chebi fb="3" ids="27226">uric acid</z:chebi> is a strong and independent risk factor for <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>